Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Too many samples

    So I've been given transcriptome data for ... quite a lot of samples (>500). It's all from various tumours from one specific tumour type. There's a clinical grading for how serious each tumour is.

    My concern is that, given it's cancer, within the groups formed by the clinical grading, there's probably a fair amount of variability. Which means that if we attempt differential expression analysis, then it's possible (likely?) that the differences within the clinical grading could obscure the differences between the groups.

    If one is looking for the best way to identify several different sets of genes for each clinical grading group, so as to be able to identify them, what's the best approach? My initial thoughts involve some form of clustering to identify sub groups within each clinical grading, but without knowing which genes to look at beforehand, that's going to end up with me attempting to cluster 20,000 odd genes, which, if I recall correctly, would be prohibitive, time-wise.

    What's the best approach for this sort of thing?

Latest Articles

Collapse

  • seqadmin
    Advanced Tools Transforming the Field of Cytogenomics
    by seqadmin


    At the intersection of cytogenetics and genomics lies the exciting field of cytogenomics. It focuses on studying chromosomes at a molecular scale, involving techniques that analyze either the whole genome or particular DNA sequences to examine variations in structure and behavior at the chromosomal or subchromosomal level. By integrating cytogenetic techniques with genomic analysis, researchers can effectively investigate chromosomal abnormalities related to diseases, particularly...
    09-26-2023, 06:26 AM
  • seqadmin
    How RNA-Seq is Transforming Cancer Studies
    by seqadmin



    Cancer research has been transformed through numerous molecular techniques, with RNA sequencing (RNA-seq) playing a crucial role in understanding the complexity of the disease. Maša Ivin, Ph.D., Scientific Writer at Lexogen, and Yvonne Goepel Ph.D., Product Manager at Lexogen, remarked that “The high-throughput nature of RNA-seq allows for rapid profiling and deep exploration of the transcriptome.” They emphasized its indispensable role in cancer research, aiding in biomarker...
    09-07-2023, 11:15 PM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, Yesterday, 09:36 AM
0 responses
8 views
0 likes
Last Post seqadmin  
Started by seqadmin, 10-02-2023, 07:14 AM
0 responses
15 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-29-2023, 09:38 AM
0 responses
16 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-27-2023, 06:57 AM
0 responses
16 views
0 likes
Last Post seqadmin  
Working...
X